Timely access to high-quality peptides is essential in drug discovery, especially for screening, structure-activity relationship (SAR) studies, and early-stage preclinical research. Any delay in peptide synthesis can slow down critical experiments, affect project timelines, and limit the ability to make rapid decisions in lead optimisation.
Recognising the critical role of fast, reliable, and risk-free peptide delivery in accelerating the development of new therapies, launched the o2h Peptide Guarantee Programme, designed to deliver peptides in just 2 weeks, to accelerate your discovery pipeline with confidence and speed.
Read on to explore how we’re setting a new standard in peptide delivery.
Programme Offerings
With the o2h Peptide Guarantee Programme, our goal is simple: deliver high-quality peptides in 2 weeks. If delayed, it’s on us.
This initiative is strategically designed to accelerate the drug discovery journey for small-molecule-focused biotech companies by providing peptides with speed, precision, and reliability. Our expertise in peptide synthesis supports the development of innovative therapies that address unmet medical needs, helping advance groundbreaking science that improves human health and the environment. Know more about the campaign here.
Highlights
- Ultra-Fast Peptide Synthesis: High-quality peptides delivered in 2 weeks. If delayed, it’s on us. T&C Applied.
- Highly Experienced Peptide Chemists: Work with our expert scientists with vast experience in synthesising and optimising complex peptide molecules with efficiency.
- End-to-End Peptide Solutions: From custom synthesis and complex modifications at mg to gram scale, to purification, analysis, and characterisation; we handle it all with precision.
- Cutting-Edge Equipment & Advanced Capabilities: o2h’s peptide facility is equipped with Biotage Syro I, CEM Liberty Blue, and more for fast, high-quality peptide production.
If you're working on a complex peptide therapeutic and require dependable, scalable support to accelerate synthesis and development, this programme is for you. Register your interest to discuss your specific project needs with our scientific team.
About o2h Discovery
Founded in 2005, o2h Discovery is a multi-award-winning CRO with a multi-modality integrated drug discovery platform, operating from Cambridge, UK, and Ahmedabad, India. We execute hit-to-lead optimisation programmes leading into patent and IND filing, with deep expertise in discovery chemistry, biology, pharmacology, and the ongoing project management of pre-clinical development.
We have experienced scientists who deliver a comprehensive range of custom peptide synthesis services, from small quantities of a few milligrams to larger amounts at gram scale. Our capabilities go beyond standard peptide synthesis services, offering specialised peptide modification services to customise and optimise peptides for diverse drug discovery programmes. Our clients include large pharma companies, leading academic institutions, and biotech firms. We’re also available on Scientist.com.
o2h Discovery’s large team of experts delivers high-quality services, covering chemistry, biology, DMPK, scale-up/PR&D, PROTAC,s (Protac Synthesis Services) LNPs, various assays including ChamelogK, supporting organizations of all sizes with cost-effective solutions from target validation all the way to IND-enabling studies.